• Scientific papers on Obstetrics and Gynecology were selected and presented at the 2024 edition of the Royal College of Obstetricians and Gynaecologists (RCOG) World Congress in Oman
  • Both papers were among the 500 chosen from a total of 10,000 submissions worldwide for publication in the highly renowned British Journal of Obstetrics and Gynecology’s forthcoming issue

Abu Dhabi, United Arab Emirates: M42’s Danat Al Emarat Hospital for Women & Children announces that its scientific studies in Obstetrics and Gynecology for advancing birthing techniques and postpartum best practices were selected and presented at the Royal College of Obstetricians and Gynaecologists (RCOG) World Congress. Selected from a total number of 10,000 submissions, the scientific papers will be published in the upcoming issue of British Journal of Obstetrics and Gynecology (BJOG Journal).

Dr. Summia Zaher, Chief Executive Officer and Medical director at Danat Al Emarat Hospital for Women & Children, said: “We are incredibly proud of the groundbreaking research conducted by our team at Danat Al Emarat Hospital for Women & Children. Having two studies recognized by the RCOG World Congress and included in the prestigious BJOG Journal is a testament to the dedication and expertise of our clinicians. This achievement underscores our commitment to providing optimal healthcare for women and children. We are passionate about women’s health and we aim to reduce C- section birth rates. I am grateful to all my colleagues who contributed to this important work, which will now reach a global audience.”

The first paper by Dr Waad Al Shehhi, Medical Resident Obstetrics & Gynecology, and Dr. Summia Zaher, Chief Executive Officer and Medical Director at Danat Al Emarat Hospital for Women & Children, highlights a rare but serious postpartum complication of a ureter rupture. The case involved a 27-year-old first-time mother with pregnancy-induced high blood pressure, who delivered a healthy baby boy at 38 weeks. Shortly after delivery, she experienced pain, fever and signs of inflammation. A CT scan revealed fluid collection and a leak along her right ureter, resulting in urine leaking into her abdomen (urinoma). Urology specialists intervened with a stent and nephrostomy to drain the kidney, resolving the issue. This case underscores the importance of considering ureter injury if persistent abdominal pain occurs postpartum, as early diagnosis and intervention are critical for preventing complications and ensuring recovery. Pregnancy-related anatomical changes can increase the risk of such ruptures.

The second paper is authored by Dr. Summia on the pain relief required by women using Dilapan-S, a device to help induce labor. The study analyzed data from over 1,500 women at UK hospitals to determine how often pain medication was needed during its use. Only 12 out of 1,509 women (0.8 percent) required pain relief during the insertion, and in just four cases, pain was not managed by painkillers. The results from this study confirmed Dilapan-S’s association with minimal usage of painkillers during childbirth.  The study concluded Dilapan-S as a safe, effective, and cost-efficient method for inducing labor, making it an excellent option for both in-hospital and outpatient care.

This year’s RCOG World Congress’ flagship event in Oman offers obstetricians and gynecologists from around the world the opportunity to learn about the latest developments in a variety of specialties over three days under the theme of ‘Transforming Women's Healthcare Through Global Collaboration’.

To learn more about Danat Al Emarat Hospital for Women & Children or to book an appointment, please call 800 96626 or visit https://danatalemarat.ae/

About Danat Al Emarat Hospital

Danat Al Emarat, part of the M42 group, is a world-class specialty women and children’s hospital located in Abu Dhabi, United Arab Emirates.

The five-story hospital, accredited as a clinical research center by the Department of Health – Abu Dhabi, covers an area of 58,000 square meters, with 225 beds. The hospital offers a comprehensive range of inpatient and outpatient medical and surgical services including Neonatology & Pediatrics, Surgery, Obstetrics & Gynecology, Internal Medicine, Women’s Diagnostics & Breast Imaging, and others, all of which are equipped with the latest technology and led by highly qualified clinicians to provide unmatched patient and family-centered care.

Our medical team is hand-picked from the international and local market specializing in numerous sub-specialties. Our 130+ consultants and primary care physicians work closely together to ensure the entire needs of women and children are addressed in a single convenient location and to the highest standards.

About M42

M42 is a first-of-its-kind, global tech-enabled health powerhouse committed to the sustainable future of health. The Abu Dhabi-headquartered company is transforming lives through innovative solutions that are solving the world’s most critical health and diagnostic challenges. By harnessing unique medical and data-centric technologies, including genomics and AI, M42 is delivering the highest level of personalized, precise, and preventative health solutions to impactfully disrupt the global health landscape.

M42 has over 20,000 employees and more than 450 facilities in 26 countries. Established in 2022, following the coming together of G42 Healthcare and Mubadala Health, M42 combines leading health technologies with state-of-the-art healthcare facilities to deliver world-class health solutions, services and care.

The M42 group includes Diaverum, Cleveland Clinic Abu Dhabi, Imperial College London Diabetes Centre and Moorfields Eye Hospital Abu Dhabi, among others.

For more information, please contact:
Maroun Farah
Senior Media Relations Manager
Weber Shandwick
e-mail: mfarah@webershandwick.com